m nn777 vip
SACRAMENTO ST. (1-4) Holt 9-18 3-6 25, Brewer 0-2 0-0 0, Neal 5-9 4-4 16, Skytta 2-8 3-7 7, Vaughns 6-10 2-3 18, Williams 3-8 1-2 7, Nunn 0-1 4-4 4, Beatty 0-0 0-0 0, Dioramma 0-1 0-0 0. Totals 25-58 17-26 77. CALIFORNIA (5-1) Ola-Joseph 2-9 4-6 10, Petraitis 5-9 2-5 13, Sissoko 3-3 4-5 10, Stojakovic 4-10 11-15 20, Tucker 2-4 0-0 5, Wilkinson 5-10 5-7 16, Dort 1-2 0-0 2, Mahoney 3-6 0-1 7. Totals 25-53 26-39 83. Halftime_California 40-33. 3-Point Goals_Sacramento St. 10-27 (Vaughns 4-6, Holt 4-10, Neal 2-5, Nunn 0-1, Skytta 0-4), California 7-26 (Ola-Joseph 2-7, Mahoney 1-3, Petraitis 1-3, Tucker 1-3, Stojakovic 1-4, Wilkinson 1-6). Fouled Out_Brewer, Skytta, Vaughns, Nunn, Sissoko. Rebounds_Sacramento St. 30 (Holt 8), California 33 (Ola-Joseph, Dort 6). Assists_Sacramento St. 13 (Skytta 5), California 12 (Petraitis 5). Total Fouls_Sacramento St. 31, California 21.The AP Top 25 men’s college basketball poll is back every week throughout the season! Get the poll delivered straight to your inbox with AP Top 25 Poll Alerts. Sign up here . FORT MYERS, Fla. (AP) — Corey Stephenson had 21 points in CSU Bakersfield’s 68-60 victory over Northeastern at the Homewood Suites Classic tournament in Fort Myers, Florida on Sunday. Stephenson shot 8 of 16 from the field and 5 for 6 from the line for the Roadrunners (4-3). Marvin McGhee shot 4 for 10 (1 for 5 from 3-point range) and 3 of 3 from the free-throw line to add 12 points. McGhee went 3 of 7 from the field (3 for 5 from 3-point range) to finish with 10 points. LA Pratt led the way for the Huskies (5-2) with 15 points and six rebounds. Masai Troutman added 15 points for Northeastern. Harold Woods also had eight points. CSU Bakersfield led Northeastern at the half, 34-29, with McGhee (six points) its high scorer before the break. Stephenson’s layup with 4:08 left in the second half gave CSU Bakersfield the lead for good at 56-54. NEXT UP These two teams both play Saturday. CSU Bakersfield visits Southern Utah and Northeastern visits Vermont. ___ The Associated Press created this story using technology provided by Data Skrive and data from Sportradar .
Swiss Re AG ( OTCMKTS:SSREY – Get Free Report ) saw a large decrease in short interest in December. As of December 15th, there was short interest totalling 24,200 shares, a decrease of 56.9% from the November 30th total of 56,200 shares. Based on an average daily volume of 54,900 shares, the short-interest ratio is presently 0.4 days. Wall Street Analyst Weigh In A number of analysts have commented on SSREY shares. The Goldman Sachs Group upgraded shares of Swiss Re from a “strong sell” rating to a “hold” rating in a research note on Friday, December 13th. Berenberg Bank upgraded Swiss Re to a “strong-buy” rating in a report on Monday, November 11th. Citigroup upgraded Swiss Re to a “strong-buy” rating in a research note on Monday, November 18th. Keefe, Bruyette & Woods upgraded Swiss Re from a “moderate sell” rating to a “hold” rating in a research note on Wednesday, November 20th. Finally, UBS Group upgraded Swiss Re from a “strong sell” rating to a “strong-buy” rating in a research note on Monday, November 11th. Two analysts have rated the stock with a hold rating and three have assigned a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Buy”. Get Our Latest Report on Swiss Re Swiss Re Trading Down 0.5 % About Swiss Re ( Get Free Report ) Swiss Re AG, together with its subsidiaries, provides wholesale reinsurance, insurance, other insurance-based forms of risk transfer, and other insurance-related services worldwide. The company operates through three segments: Property & Casualty Reinsurance, Life & Health Reinsurance, and Corporate Solutions. Featured Articles Receive News & Ratings for Swiss Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Swiss Re and related companies with MarketBeat.com's FREE daily email newsletter .Trump’s TikTok love raises stakes in battle over app’s fateHold Tight: What Every Dividend Investor Needs To Know Now
// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC , Dec. 13, 2024 /CNW/ -- BioVaxys Technology Corp. BIOV 5LB (" BioVaxys " or the " Company ") is pleased to announce that it has closed the first tranche (the " First Tranche ") of its previously announced non-brokered private placement (the " Private Placement ") with the issuance of 2,200,000 units (the " Units ") of the Company at a price of $0.05 per Unit for aggregate gross proceeds of $110,000 . Each Unit consist of one (1) common share in the capital of the Company (each, a " Share ") and one (1) whole Share purchase warrant (each, a " Warrant "), whereby each Warrant is convertible into one additional Share at an exercise price of $0.15 until December 13, 2026 , being the date that is 24 months from the date of issue. The Company intends to use the net proceeds of the First Tranche for working capital. No finder's fees were paid in connection with the First Tranche. All securities issued pursuant to the First Tranche are subject to a statutory hold period expiring April 14, 2025 , being the date that is four months and one day from the date of issuance in accordance with applicable securities legislation In addition, the Company announces that it has entered into a debt settlement agreement with an arm's-length consultant of the Company to settle an aggregate of $500,000 in debt owed to the consultant by issuing 5,000,000 Shares at a deemed price of $0.10 per Share (the " Debt Settlement "). The board of directors of the Company has determined that it is in the best interests of the Company to settle the outstanding debt through the issuance of Shares in order to preserve the Company's cash for working capital purposes. All securities proposed to be issued pursuant to the Debt Settlement will be subject to a statutory hold period of four months from the date of issuance in accordance with applicable securities legislation. Closing of the Debt Settlement is conditional upon a number of conditions, including receipt of all applicable corporate and regulatory approvals, including the acceptance of the Canadian Securities Exchange. This news release does not constitute an offer to sell or a solicitation of an offer to buy of any securities in the United States . The securities described herein have not been, and will not be, registered under the United States Securities Act of 1933 , as amended (the " U.S. Securities Act "), or any state securities laws, and may not be offered or sold within the United States except in compliance with the registration requirements of the U.S. Securities Act and applicable state securities laws or pursuant to available exemptions therefrom. About BioVaxys Technology Corp. BioVaxys Technology Corp. ( www.biovaxys.com ), a company registered in British Columbia, Canada , is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPXTM immune-educating technology platform and it's HapTenix© 'neoantigen' tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. DPXTM is a patented antigen delivery platform that can incorporate a range of bioactive molecules to produce targeted, long-lasting immune responses enabled by various formulated components. The DPX platform facilitates antigen delivery to regional lymph nodes and has been demonstrated to induce robust and durable T cell and B cell responses in pre-clinical and clinical studies for both cancer and infectious disease. BioVaxys' common shares are listed on the Canadian Securities Exchange under the stock symbol "BIOV", on the Frankfurt Bourse 5LB , and quoted in the US on the OTC Markets. For more information, visit www.biovaxys.com and connect with us on X and LinkedIn. ON BEHALF OF THE BOARD Signed " James Passin " James Passin , Chief Executive Officer Phone: +1 740 358 0555 Cautionary Statements Regarding Forward Looking Information This news release includes certain "forward-looking information" and "forward-looking statements" (collectively " forward-looking statements ") within the meaning of applicable securities legislation. All statements, other than statements of historical fact, included herein, without limitation, the statements relating to the Private Placement and the Debt Settlement, including the expected use of proceeds from the Private Placement and related issuance of the Shares for the Debt Settlement, are forward-looking statements. Forward-looking statements are frequently, but not always, identified by words such as "expects", "anticipates", "believes", "intends", "estimates", "potential", "possible", and similar expressions, or statements that events, conditions, or results "will", "may", "could", or "should" occur or be achieved. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those expressed or implied in such forward-looking statements. These forward-looking statements reflect the beliefs, opinions and projections on the date the statements are made and are based upon a number of assumptions and estimates, primarily the assumption that BioVaxys will be successful in developing and testing vaccines, that, while considered reasonable by BioVaxys, are inherently subject to significant business, economic, competitive, political and social uncertainties and contingencies. Many factors, both known and unknown, could cause actual results, performance or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements and the parties have made assumptions and estimates based on or related to many of these factors. Such factors include, without limitation, the impact of any changes that may affect the anticipated use of proceeds from the Private Placement and the ability of the Company to obtain the necessary approvals to proceed with the Debt Settlement. BioVaxys does not assume any obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by applicable securities laws. The Canadian Securities Exchange has not reviewed, approved nor disapproved the contents of this press release and does not accept responsibility for the adequacy or accuracy of this release. Logo - https://mma.prnewswire.com/media/2415135/5078410/BioVaxys_Technology_Corp_Logo.jpg View original content: https://www.prnewswire.com/news-releases/biovaxys-announces-closing-of-first-tranche-of-private-placement-and-announces-debt-settlement-agreement-302331766.html SOURCE BioVaxys Technology Corp. View original content: http://www.newswire.ca/en/releases/archive/December2024/13/c5212.html © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC , Dec. 13, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (" BioVaxys " or the " Company ") is pleased to announce that it has closed the first tranche (the " First Tranche ") of its previously announced non-brokered private placement (the " Private Placement ") with the issuance of 2,200,000 units (the " Units ") of the Company at a price of $0.05 per Unit for aggregate gross proceeds of $110,000 . Each Unit consist of one (1) common share in the capital of the Company (each, a " Share ") and one (1) whole Share purchase warrant (each, a " Warrant "), whereby each Warrant is convertible into one additional Share at an exercise price of $0.15 until December 13, 2026 , being the date that is 24 months from the date of issue. The Company intends to use the net proceeds of the First Tranche for working capital. No finder's fees were paid in connection with the First Tranche. All securities issued pursuant to the First Tranche are subject to a statutory hold period expiring April 14, 2025 , being the date that is four months and one day from the date of issuance in accordance with applicable securities legislation In addition, the Company announces that it has entered into a debt settlement agreement with an arm's-length consultant of the Company to settle an aggregate of $500,000 in debt owed to the consultant by issuing 5,000,000 Shares at a deemed price of $0.10 per Share (the " Debt Settlement "). The board of directors of the Company has determined that it is in the best interests of the Company to settle the outstanding debt through the issuance of Shares in order to preserve the Company's cash for working capital purposes. All securities proposed to be issued pursuant to the Debt Settlement will be subject to a statutory hold period of four months from the date of issuance in accordance with applicable securities legislation. Closing of the Debt Settlement is conditional upon a number of conditions, including receipt of all applicable corporate and regulatory approvals, including the acceptance of the Canadian Securities Exchange. This news release does not constitute an offer to sell or a solicitation of an offer to buy of any securities in the United States . The securities described herein have not been, and will not be, registered under the United States Securities Act of 1933 , as amended (the " U.S. Securities Act "), or any state securities laws, and may not be offered or sold within the United States except in compliance with the registration requirements of the U.S. Securities Act and applicable state securities laws or pursuant to available exemptions therefrom. About BioVaxys Technology Corp. BioVaxys Technology Corp. ( www.biovaxys.com ), a company registered in British Columbia, Canada , is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPXTM immune-educating technology platform and it's HapTenix© 'neoantigen' tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. DPXTM is a patented antigen delivery platform that can incorporate a range of bioactive molecules to produce targeted, long-lasting immune responses enabled by various formulated components. The DPX platform facilitates antigen delivery to regional lymph nodes and has been demonstrated to induce robust and durable T cell and B cell responses in pre-clinical and clinical studies for both cancer and infectious disease. BioVaxys' common shares are listed on the Canadian Securities Exchange under the stock symbol "BIOV", on the Frankfurt Bourse (FRA: 5LB), and quoted in the US on the OTC Markets. For more information, visit www.biovaxys.com and connect with us on X and LinkedIn. ON BEHALF OF THE BOARD Signed " James Passin " James Passin , Chief Executive Officer Phone: +1 740 358 0555 Cautionary Statements Regarding Forward Looking Information This news release includes certain "forward-looking information" and "forward-looking statements" (collectively " forward-looking statements ") within the meaning of applicable securities legislation. All statements, other than statements of historical fact, included herein, without limitation, the statements relating to the Private Placement and the Debt Settlement, including the expected use of proceeds from the Private Placement and related issuance of the Shares for the Debt Settlement, are forward-looking statements. Forward-looking statements are frequently, but not always, identified by words such as "expects", "anticipates", "believes", "intends", "estimates", "potential", "possible", and similar expressions, or statements that events, conditions, or results "will", "may", "could", or "should" occur or be achieved. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those expressed or implied in such forward-looking statements. These forward-looking statements reflect the beliefs, opinions and projections on the date the statements are made and are based upon a number of assumptions and estimates, primarily the assumption that BioVaxys will be successful in developing and testing vaccines, that, while considered reasonable by BioVaxys, are inherently subject to significant business, economic, competitive, political and social uncertainties and contingencies. Many factors, both known and unknown, could cause actual results, performance or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements and the parties have made assumptions and estimates based on or related to many of these factors. Such factors include, without limitation, the impact of any changes that may affect the anticipated use of proceeds from the Private Placement and the ability of the Company to obtain the necessary approvals to proceed with the Debt Settlement. BioVaxys does not assume any obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by applicable securities laws. The Canadian Securities Exchange has not reviewed, approved nor disapproved the contents of this press release and does not accept responsibility for the adequacy or accuracy of this release. Logo - https://mma.prnewswire.com/media/2415135/5078410/BioVaxys_Technology_Corp_Logo.jpg
Tel-Aviv, Israel, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Ellomay Capital Ltd. (NYSE American; TASE: ELLO) (“Ellomay” or the “Company”), a renewable energy and power generator and developer of renewable energy and power projects in Europe, USA and Israel, today announced that it will hold an extraordinary general meeting of shareholders (the “Meeting”) at the Company’s offices at 18 Rothschild Boulevard, 1st Floor, Tel Aviv 6688121, Israel, on Thursday, January 30, 2025, at 3:00 p.m., Israel time, and thereafter as it may be adjourned or postponed from time to time. The agenda of the Meeting will be to approve the terms of service and compensation of Mr. Ben Sheizaf, the Company’s Chairman of the Board. Shareholders of record as of the close of business on December 30, 2024 will be entitled to vote at the Meeting or any adjournments or postponements thereof. The Company plans to mail a proxy statement that describes the proposal to be considered at the Meeting and a proxy card on or about December 31, 2024. A proxy statement and proxy card will also be furnished to the Securities and Exchange Commission on Form 6-K on or about December 23, 2024. The resolution to be presented at the Meeting requires the affirmative vote of holders of at least a majority of the ordinary shares voted at the Meeting on the matter presented for passage, in person or by proxy or via the electronic system of the Israel Securities Authority. Eligible shareholders may present proper proposals for inclusion in the Meeting by submitting their proposals to the Company no later than December 30, 2024. Shareholders may vote their ordinary shares by means of a proxy card, which is required to be received by the Company, along with the documentation set forth in the proxy statement, by 11:00 a.m., Israel time, on January 30, 2025 (four hours prior to the Meeting), to be counted for the Meeting, or through the electronic system of the Israel Securities Authority until six hours prior to the Meeting. About Ellomay Capital Ltd. Ellomay is an Israeli based company whose shares are listed on the NYSE American and the Tel Aviv Stock Exchange under the trading symbol “ELLO”. Since 2009, Ellomay Capital focuses its business in the renewable energy and power sectors in Europe, USA and Israel. To date, Ellomay has evaluated numerous opportunities and invested significant funds in the renewable, clean energy and natural resources industries in Israel, Italy, Spain, the Netherlands and Texas, USA, including: For more information about Ellomay, visit http://www.ellomay.com . Information Relating to Forward-Looking Statements This press release contains forward-looking statements that involve substantial risks and uncertainties, including statements that are based on the current expectations and assumptions of the Company’s management. All statements, other than statements of historical facts, included in this press release regarding the Company’s plans and objectives, expectations and assumptions of management are forward-looking statements. The use of certain words, including the words “estimate,” “project,” “intend,” “expect,” “believe” and similar expressions are intended to identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company may not actually achieve the plans, intentions or expectations disclosed in the forward-looking statements and you should not place undue reliance on the Company’s forward-looking statements. Various important factors could cause actual results or events to differ materially from those that may be expressed or implied by the Company’s forward-looking statements, including changes in electricity prices and demand, continued war and hostilities in Israel, regulatory changes, including extension of current or approval of new rules and regulations increasing the operating expenses of manufacturers of renewable energy in Spain, increases in interest rates and inflation, changes in the supply and prices of resources required for the operation of the Company’s facilities (such as waste and natural gas) and in the price of oil, the impact of continued military conflict between Russia and Ukraine, technical and other disruptions in the operations or construction of the power plants owned by the Company and general market, political and economic conditions in the countries in which the Company operates, including Israel, Spain, Italy and the United States. These and other risks and uncertainties associated with the Company’s business are described in greater detail in the filings the Company makes from time to time with Securities and Exchange Commission, including its Annual Report on Form 20-F. The forward-looking statements are made as of this date and the Company does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. Contact: Kalia Rubenbach (Weintraub) CFO Tel: +972 (3) 797-1111 Email: hilai@ellomay.com
Walmart’s Mexico subsidiary plans to appeal a $4.6 million fine for alleged monopolistic practices
NoneNFC's No. 1 seed comes down to Vikings-Lions showdown at Detroit in Week 18 The NFC’s No. 1 seed will come down to the final week when the Detroit Lions host the Minnesota Vikings. The winner takes the NFC North and gets a first-round playoff bye and home-field advantage until the Super Bowl. The loser becomes the No. Rob Maaddi, The Associated Press Dec 29, 2024 6:16 PM Dec 29, 2024 6:35 PM Share by Email Share on Facebook Share on X Share on LinkedIn Print Share via Text Message Minnesota Vikings' Jordan Addison celebrates his touchdown catch with Justin Jefferson during the second half of an NFL football game against the Green Bay Packers Sunday, Dec. 29, 2024, in Minneapolis. (AP Photo/Abbie Parr) The NFC’s No. 1 seed will come down to the final week when the Detroit Lions host the Minnesota Vikings. The winner takes the NFC North and gets a first-round playoff bye and home-field advantage until the Super Bowl. The loser becomes the No. 5 seed and must play on the road in the wild-card round. The Vikings (14-2) held on for a 27-25 victory over the Green Bay Packers to set up the high-stakes showdown in Week 18. The Lions (13-2) visit the San Francisco 49ers (6-9) on Monday night in a rematch of the NFC title game. Win, lose or tie, they have to beat the Vikings again. Detroit beat Minnesota 31-29 in Week 7. The Philadelphia Eagles clinched the NFC East and locked up the No. 2 seed with a 41-7 rout of the Dallas Cowboys. However, coach Nick Sirianni has a tough decision to make this week. Saquon Barkley is 101 yards away from breaking Eric Dickerson’s single-season record for yards rushing in a season. Sirianni has to decide whether to rest Barkley and most of his starters to prepare for the playoffs or let his star try for the 40-year-old record. The Los Angeles Rams (10-6) were on the verge of clinching the NFC West. They would lock it up Sunday night if the Commanders beat the Falcons. The outcome of the Atlanta-Washington game has a major impact on the Tampa Bay Buccaneers (9-7). If the Falcons win, they’d remain first in the NFC South and would win the division with a victory against Carolina next week. If the Falcons lose, the Buccaneers would take over first place and would secure the division with a victory over New Orleans next week. The Commanders would secure a wild-card spot with a win against Atlanta. If they lose, Seattle stays mathematically alive for a wild card and the Buccaneers could also find a path to the playoffs as a wild-card team. Three teams in the AFC have already secured their seeds. The two-time defending Super Bowl champion Kansas City Chiefs (15-1) won the AFC West weeks ago and clinched the No. 1 seed. The AFC East champion Buffalo Bills (13-3) are the No. 2 seed. The AFC South champion Houston Texans (9-7) are the No. 4 seed. The Baltimore Ravens (11-5) would win the AFC North and get the No. 3 seed with a win or tie against Cleveland next weekend or a loss or tie by Pittsburgh, which hosts Cincinnati. If they don’t win the division, the Steelers have already clinched a wild-card berth. The Los Angeles Chargers (10-6) also secured a wild-card spot. They’ll be no lower than the sixth seed. The final AFC playoff spot comes down to the Broncos (9-7), Dolphins (8-8) or Bengals (8-8). Denver clinches with a win or tie against the Chiefs. The Dolphins need the Broncos to lose and they must beat the Jets on the road to get in. The Bengals must win and the Broncos and Dolphins have to lose for them to get in. ___ AP NFL: https://apnews.com/hub/NFL Rob Maaddi, The Associated Press See a typo/mistake? Have a story/tip? This has been shared 0 times 0 Shares Share by Email Share on Facebook Share on X Share on LinkedIn Print Share via Text Message Get your daily Victoria news briefing Email Sign Up More Football (NFL) Darnold gives Vikings another gem with career-high 377 yards in 27-25 win over Packers Dec 29, 2024 6:26 PM Huntley fills in for injured Tagovailoa, leads Dolphins past Browns 20-3 to keep playoff hopes alive Dec 29, 2024 5:53 PM Moment of silence for former President Jimmy Carter held before the Falcons-Commanders game Dec 29, 2024 5:52 PM
Movie Review: Nicole Kidman commands the erotic office drama ‘Babygirl’
Inter beats Como and closes gap at the top of Serie A while Bove back on Fiorentina sideline FLORENCE, Italy (AP) — Inter Milan beat Como 2-0 to cement third place in Serie A and close the gap on top two Atalanta and Napoli on Monday. Carlos Augusto got the opener when he headed home a corner kick in the 48th minute. Canadian Press Dec 23, 2024 1:56 PM Share by Email Share on Facebook Share on X Share on LinkedIn Print Share via Text Message Inter Milan's Carlos Augusto, center, celebrates after scoring against Como during a Serie A soccer match between Inter Milan and Como at the San Siro stadium in Milan, Italy, Monday, Dec. 23, 2024. (AP Photo/Luca Bruno) FLORENCE, Italy (AP) — Inter Milan beat Como 2-0 to cement third place in Serie A and close the gap on top two Atalanta and Napoli on Monday. Carlos Augusto got the opener when he headed home a corner kick in the 48th minute. Marcus Thuram scored the second in stoppage time with a potent strike into the roof of the net. It was the first time these teams have played each other in the top division since 2003 and although Inter had lost only one league game all season it struggled to impose itself on 15th-placed Como. However, it won without exerting itself and the three points were enough to take Simone Inzaghi’s men within three points of leader Atalanta and within one of Napoli. Inter has a game in hand over both clubs. Fiorentina misses chance to rise Fiorentina missed a chance to go fourth when it lost at home to Udinese 2-1. The Florence club won a record eight consecutive Serie A games before losing to Bologna 1-0 on Dec. 15, and it looked to be back on track when Moises Kean converted a penalty after eight minutes to become the first Fiorentina player to reach double figures in the league since Federico Chiesa in the 2019-20 season. However, Udinese was a different prospect after the break. Lorenzo Lucca equalized with the aid of sloppy defending four minutes into the second half and then Florian Thauvin found space on the edge of the box to curl in the second eight minutes later. The result left Udinese in ninth place and Fiorentina in fifth. The match was a special one for Edoardo Bove, the Fiorentina player whose collapse with a heart issue led to the suspension of its game with Inter Milan on Dec. 1. Bove was fitted with a defibrillator implant soon after and sat on the Fiorentina bench for the first time since his collapse. He is not allowed to play but his position on the sideline alongside coach Raffaele Palladino was seen as a step towards normality for the 22-year-old midfielder. ___ AP soccer: https://apnews.com/hub/soccer The Associated Press See a typo/mistake? Have a story/tip? This has been shared 0 times 0 Shares Share by Email Share on Facebook Share on X Share on LinkedIn Print Share via Text Message Get your daily Victoria news briefing Email Sign Up More Soccer FIFPRO against FIFA's temporary changes to transfer rules Dec 23, 2024 11:22 AM World Cup winner Alessandro Nesta fired by last-place Serie A club Monza Dec 23, 2024 8:12 AM Australia is banning social media for teens. Should Canada do the same? Dec 23, 2024 7:13 AM
Jimmy Carter: Many evolutions for a centenarian ‘citizen of the world’
Bristow Group Inc. (NYSE:VTOL) Shares Bought by Barclays PLCAP News Summary at 5:30 p.m. EST
BILLERICA — The Billerica Police Department announced the recent promotions of Lt. Mark Tsoukalas and Sgts. Ryan Koles and Rocco Magliozzi to new leadership roles within the force. “The Town of Billerica is fortunate to have these three professionals working in such important roles,” Chief Roy Frost said in a press release making the announcement. “Police leadership is the foundation of a safe, supportive and flourishing community. I am confident these promotions will align well with those objectives.” • Tsoukalas, a veteran of the Billerica Police Department since 1999, was key in restarting the K-9 program in 2003 after years without it. He also served in the Northeastern Massachusetts Law Enforcement Council K-9 Unit from 2004 to 2024, and was its commander for a time. Promoted to sergeant in 2019, Tsoukalas oversaw the Traffic Department in 2024. He also updated the field training officer program and holds a bachelor’s from Suffolk University. In his new role, Tsoukalas will be the officer in charge of the midnight to 8 a.m. shift. • Koles, who holds a bachelor’s degree from Westfield University, has served with the Billerica Police Department since 2014 after working two years with the Dunstable Police Department. He is a longtime field training officer and part of the Billerica Police Honor Guard. Koles became a K-9 handler in 2023 and has been recognized for finding missing or suicidal individuals with his K-9 partner, Cassius. He will now serve as a patrol sergeant on the midnight to 8 a.m. shift. • Magliozzi has been with the Billerica Police Department since 2014 and became a K-9 handler in 2018. Known for his work with his K-9 partner, Skye, Magliozzi has found numerous missing or suicidal individuals and has been recognized for finding crucial evidence in serious crimes. Magliozzi, who holds a bachelor’s degree from the University of Massachusetts, is also a field training officer and plays a big role in the department’s Community Policing and Social Media units. He will now serve as a patrol sergeant on the 4 p.m. to midnight shift. Follow Aaron Curtis on X, formerly known as Twitter, @aselahcurtis
MANCHESTER, England (AP) — Pep Guardiola committed himself to Manchester City for another two years on Thursday and quickly set his sights on adding to his record-breaking reign. Guardiola ended uncertainty about his future by signing a contract extension that would prolong his tenure as City manager to 11 seasons. “I have said this many times before, but I have everything a manager could ever wish for," said the 53-year-old Catalan coach, whose current deal was due to expire at the end of this season. "Hopefully now we can add more trophies to the ones we have already won. That will be my focus.” Guardiola has overseen a period of unprecedented dominance since joining City in 2016. He has gone on to win six Premier League titles in seven years at the Etihad Stadium and also won the Champions League. In total, he has won 15 major trophies at the club. He has set new benchmarks, with City becoming the first team to win four-straight English league titles and the first to amass 100 points in a single season in 2018. He also led City to the treble in 2023, winning the Premier League, Champions League and FA Cup in one season — matching Manchester United's achievement in 1999. “Manchester City means so much to me. This is my ninth season here. We have experienced so many amazing times together. I have a really special feeling for this football club,” Guardiola added in his statement. “That is why I am so happy to be staying for another two more seasons.” Publicly, Guardiola gave no indication about whether he would stay on even as he entered the final months of his contract. That led to speculation about potential successors, but City remained hopeful he could be convinced to sign another extension. He has already managed City for longer than any his former clubs, having spent four years at Barcelona and three at Bayern Munich. City Chairman Khaldoon Al Mubarak said he was “delighted” that Guardiola is staying. “His hunger for improvement and success remains insatiable and the direct beneficiaries of that will continue to be our players and coaching staff, the culture of our club, and the English game at large,” he said. Story continues below video “This renewal will take Pep beyond a decade of coaching Manchester City and the opportunity to continue to re-write the managerial record books.” Guardiola's new deal comes at a time when City's Premier League dominance appears to be under threat . The four-time defending champion has lost four games in succession in all competitions — the worst losing streak of Guardiola's managerial career. Guardiola is widely considered one of the greatest managers of all time, having been a serial winner at Barcelona, Bayern and City. He has won 33 major titles with those clubs, including three Champions League trophies. His decision to stay at City also comes as the club faces a slew of alleged financial breaches . Punishment could be as extreme as expulsion from the league. City faces more than 100 charges ranging over a nine-year period when it was trying to establish itself as the biggest force in English soccer. The club denies the charges and Guardiola had said in September — when a closed-door hearing was scheduled — that he welcomed the chance to clear the club’s name. A verdict is not expected until next year. James Robson is at https://twitter.com/jamesalanrobson AP soccer: https://apnews.com/hub/soccerBEIRUT (AP) — Syria's de facto leader said Sunday it could take up to four years to hold elections in Syria, and that he plans to dissolve his Islamist group that led the country's insurgency at an anticipated national dialogue summit for the country. Ahmad al-Sharaa, who leads Hayat Tahrir al-Sham, the group leading the new authority in Syria, made the remarks in an interview with Saudi television network Al-Arabiyya. It comes almost a month after a lightning insurgency led by HTS overthrew President Bashar Assad's decades-long rule, ending the country's uprising-turned civil war that started back in 2011. Al-Sharaa said it would take time to hold elections because of the need for Syria's different forces to hold political dialogue and rewrite the country's constitution following five decades of the Assad dynasty's dictatorial rule. Also, the war-torn country's battered infrastructure needs to be reconstructed, he said. “The chance we have today doesn’t come every 5 or 10 years,” said al-Sharaa, formerly known as Abu Mohammed al-Golani. “We want the constitution to last for the longest time possible.” Al-Sharaa is Syria's de facto leader until March 1, when Syria's different factions are set to hold a political dialogue to determine the country's political future and establish a transitional government that brings the divided country together. There, he said, HTS will dissolve after years of being the country's most dominant rebel group that held a strategic enclave in the country's northwest. Earlier, an Israeli airstrike in the outskirts of Damascus on Sunday killed 11 people, according to a war monitor, as Israel continues to target Syrian weapons and military infrastructure even after the ouster of Assad. The Britain-based Syrian Observatory for Human Rights said the airstrike targeted a weapons depot that belonged to Assad’s forces near the industrial town of Adra, northeast of the capital. The observatory said at least 11 people, mostly civilians, were killed. The Israeli military did not comment on the airstrike Sunday. Israel, which has launched hundreds of airstrikes over Syria since the country's uprising turned-civil war broke out in 2011, rarely acknowledges them. It says its targets are Iran-backed groups that backed Assad. Unlike his criticism of key Assad ally Iran, al-Sharaa hoped to maintain “strategic relations” with Russia, whose air force played a critical role in keeping Assad in power for over a decade during the conflict. Moscow has a strategic airbase in Syria. The HTS leader also said negotiations are ongoing with the Kurdish-led Syrian Democratic Forces in northeastern Syria, and hopes that their armed forces will integrate with the Syrian security agencies. The Kurdish-led group is Washington’s key ally in Syria, where it is heavily involved in targeting sleeper cells belonging to the extremist Islamic State group. Turkish-backed Syrian rebels have been clashing with the SDF even after the insurgency, taking the key city of Manbij, as Ankara hopes to create a buffer zone near its border in northern Syria. The rebels attacked near the strategic northern border town of Kobani, while the SDF shared a video of a rocket attack that destroyed what it said was a radar system south of the city of Manbij. In other developments: — Syrian state-run media said a mass grave was found near the third largest city of Homs. SANA said civil defense workers were sent to to the site in al-Kabo, one of many suspected mass graves where tens of thousands of Syrians are believed to have been buried during a brutal crackdown under Assad and his network of security agencies. — An Egyptian activist wanted by Cairo on charges of incitement to violence and terrorism, Abdulrahman al-Qardawi, was detained by Lebanese security forces after crossing the porous border from Syria, according to two judicial and one security officials who spoke on condition of anonymity because they were not authorized to to talk to the press. Al-Qardawi is an Egyptian activist residing in Turkey and an outspoken critic of Egypt's government. He had reportedly visited Syria to join celebrations after Assad's downfall. His late father, Youssef al-Qaradawi, was a top and controversial Egyptian cleric revered by the outlawed Muslim Brotherhood. He had lived in exile in Qatar for decades. — Lebanese security forces apprehended an armed group in the northern city of Tripoli that kidnapped a group of 26 Syrians who were recently smuggled into Lebanon, two Lebanese security officials said on condition of anonymity because they were not authorized to share the information with the media. The Syrians included five women and seven children, and security officials are working to return them to Syria.
Seibert misses an extra point late as the Commanders lose their 3rd in a row, 34-26 to the CowboysAP News Summary at 5:42 p.m. EST